Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 15/20 | 0.38 |
| ▸ | TOP2A | P11388 | 2/20 | 0.36 |
| ▸ | TOP2B | Q02880 | 2/20 | 0.36 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
| ▸ | FOXO1 | Q12778 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9865154 | 0.90 | FOXO1 (0.35) | GSK3BTOP2ATOP2BCACNA1FPOLB | |
| SCHEMBL9866155 | 0.77 | KDM4E (0.36) | GSK3BTOP2ATOP2BPOLB | |
| SCHEMBL4716155 | 0.69 | GSK3B (0.59) | GSK3BTOP2ATOP2BCACNA1FPOLB | |
| SCHEMBL9865852 | 0.67 | CHRM1 (0.34) | — | |
| SCHEMBL4713790 | 0.65 | TOP2A (0.61) | GSK3BTOP2ATOP2BCACNA1FPOLB | |
| SCHEMBL4673155 | 0.63 | TOP2A (0.44) | GSK3BTOP2ATOP2BCACNA1FPOLB | |
| SCHEMBL4673154 | 0.63 | TOP2A (0.44) | GSK3BTOP2ATOP2BCACNA1FPOLB | |
| SCHEMBL4719276 | 0.63 | GSK3B (0.56) | GSK3BTOP2ATOP2BCACNA1FPOLB | |
| SCHEMBL6786216 | 0.62 | GSK3B (0.40) | GSK3BTOP2ATOP2BCACNA1FPOLB | |
| SCHEMBL3134076 | 0.61 | KCNH2 (0.38) | GSK3BTOP2ATOP2BPOLBKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4992546-A | Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives | WARNER-LAMBERT COMPANY (US) | 1991-02-12 | — | — | US | disclosed |
| US-4968799-A | Antibacterial agents | WARNER-LAMBERT COMPANY (US) | 1990-11-06 | — | — | US | disclosed |
| US-4962108-A | A QUIN-4-ONE HAVING THE FOLLOWING RING SUBSTITUENTS; 1-ALKYL OR PHENYL, 3-CARBOXY DERIVATIVE, 6-FLUORO AND 8-BRIDGED N-HETEROCYCLIC RING | WARNER-LAMBERT COMPANY (US) | 1990-10-09 | — | — | US | disclosed |
| US-4923879-A | CARBOXYLIC ACID DERIVATIVES WITH BRIDGED SIDECHAINS | WARNER-LAMBERT COMPANY (US) | 1990-05-08 | — | — | US | disclosed |
| EP-0305744-A2 | Quinoline, naphthyridine and benzoxazine-carboxylic acid derivatives and their use as antibacterial agents | WARNER-LAMBERT COMPANY (US) | 1989-03-08 | — | — | EP | disclosed |